Compass Therapeutics (CMPX) PT Lowered to $6 at Stifel

April 27, 2026 2:52 PM

Stifel analyst Stephen Willey lowered the price target on Compass Therapeutics (NASDAQ: CMPX) to $6.00 (from $12.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found